"MedPharmics is a clinical research consortium with 8 sites located in Louisiana, Mississippi, Arizona, New Mexico, and Alabama. Our sites enlist “Medical Heroes” for clinical research trials to determine the efficacy and safety of new medications or devices while ensuring the safety and protection of our participants."

During the past decade, MedPharmics, LLC conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 27 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 20 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MedPharmics, LLC" #1 sponsor was "Pfizer" with 15 trials, followed by "ModernaTX, Inc." with 7 trials sponsored, "Janssen Vaccines & Prevention B.V." with 3 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "AOBiome LLC" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MedPharmics, LLC" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 2 trials as a collaborator, "Bavarian Nordic" with 1 trials as a collaborator, "Health Decisions" with 1 trials as a collaborator, "IQVIA Inc." with 1 trials as a collaborator and "Innovis LLC" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "MedPharmics, LLC" are "SARS-CoV-2" (3 trials), "COVID-19 Pneumonia" (2 trials), "Influenza A" (2 trials), "Influenza, Human" (2 trials) and "Migraine" (2 trials). Many other conditions were trialed in "MedPharmics, LLC" in a lesser frequency.

Most popular intervention types in "MedPharmics, LLC" are "Biological" (25 trials), "Drug" (23 trials), "Other" (7 trials), "Device" (5 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Rimegepant" (3 trials), "13vPnC" (2 trials), "Multivalent" (2 trials) and "RSVpreF" (2 trials). Other intervention names were less common.

The vast majority of trials in "MedPharmics, LLC" are 44 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "MedPharmics, LLC". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in MedPharmics, LLC, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in MedPharmics, LLC, 5 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".